Curie Brief
Turn on cookies to sign in
Signing in saves your progress to your Curie account. We can only do that with cookies on — turn them on to continue.
News
Social media is flooding feeds with misleading claims about Alzheimer's blood tests, often pushing them as screening tools for healthy people — which goes against current medical guidelines. A new study found that over a third of posts misrepresented the tests, and nearly 1 in 5 came from accounts with a financial stake. Clinicians are urged to counsel patients on what these tests can — and can't — do.
Social media platforms are awash with misleading posts about Alzheimer's blood tests, and a new study published in the Journal of the American Geriatrics Society is sounding the alarm. Researchers from the University of Sydney analyzed 188 posts across Facebook, Instagram, and TikTok — collectively reaching over 114 million followers — and found that a significant portion misrepresented how and when these tests should be used.
The biggest concern: more than a third of posts portrayed the tests as useful screening tools for people with no memory or thinking symptoms, directly contradicting 2024 Alzheimer's Association guidelines. Those guidelines are clear — blood-based biomarker tests should only be ordered by a clinician for patients already showing signs of cognitive decline.
By the Numbers:
Why it matters: Misinformation about Alzheimer's blood tests isn't just misleading — it's potentially harmful. False positives in asymptomatic people can trigger unnecessary anxiety and lead to overdiagnosis. Clinicians need to proactively address patient questions about these tests, clarify what a positive or negative result actually means, and help patients identify financially motivated sources online.
